Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report

We report a case in which selegiline, an irreversible monoamine oxidase B (MAO-B) inhibitor, greatly improved depressive symptoms in an adult with stage 5 treatment-resistant major depressive disorder. Four antidepressants and four augmentation therapies had previously been ineffective or intolerabl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kitaichi, Yuji, Inoue, Takeshi, Mitsui, Nobuyuki, Nakagawa, Shin, Kameyama, Rie, Hayashishita, Yoshiyuki, Shiga, Tohru, Kusumi, Ichiro, Koyama, Tsukasa
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804584/
https://ncbi.nlm.nih.gov/pubmed/24204150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S49261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados